Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

Father, son develop drug to fight brain diseases
February 20, 2012

The relationship is a rare one in science: a father and son, one a highly credentialed chemist, the other an up-and-coming biologist, working together on a new drug that, if it works, could be among the first to treat terrible brain diseases such as Alzheimer's and Huntington's.

HIV drug tenofovir increases risk of kidney damage
February 18, 2012

Patients who take one of the most widely prescribed drugs to treat HIV infection increase their risk of kidney damage by up to 34 percent every year they take the medication, according to a study of more than 10,000 HIV-positive veterans.

Stem cells found to help heart heal after attack
February 15, 2012

Stem cells grown from patients' own cardiac tissue can heal damage once thought to be permanent after a heart attack, according to a study that suggests the experimental approach may one day help stave off heart failure.

Skin cells as stem cells
February 14, 2012

Dr. Deepak Srivastava and Dr. Sheng Ding are two of the many minds at Gladstone Institute, using not adult stem cells or embryonic stem cells, but your own skin cells to repair bodies from the inside out

Stem Cells Heal Scar Damage After Heart Attack
February 14, 2012

For the first time, researchers have used stem cells from a patient's own heart to repair the damage to the muscle that occurs during heart attack.

Scarred Hearts Can Be Mended With Novel Stem Cell Therapy, Study Finds
February 13, 2012

Stem cells grown from patients' own cardiac tissue can heal damage once thought to be permanent after a heart attack, according to a study that suggests the experimental approach may one day help stave off heart failure. Places to display: Cardiovascular Disease, Stem Cell Research, Deepak Srivastava

One-on-One with the Gladstone Institutes' Michael Penn
February 7, 2012

Penn, who spent the past eight years as a product and business development manager at biotech powerhouse Genentech Inc. in South San Francisco, was hired last month as the first vice president for strategy at the Gladstone Institutes.

FDA to consider HIV prevention pills
February 4, 2012

February 4, 2012 - Gladstone Investigator Robert Grant, MD, MPH is quoted in this article about Gilead's FDA application to allow the drug Truvada to be prescribed to prevent HIV-1 infection.

Stem Cell Therapy Promising in Progressive MS
January 31, 2012

Katerina Akassoglou, PhD, from the Gladstone Institute of Neurological Disease comments on a finding which suggests that stem cells may have neuroprotective effects in multiple sclerosis.

Feature: What foods really help stave of heart disease?
January 27, 2012

The Gladstone Institutes in San Francisco recently found that a genetic switch in an unborn baby could be the key to whether they will develop heart disease in later life.